← Eichor
Study identifier: NCT06122259 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Febrile Illness in Guinea

Condition: Febrile Illness  ·  Sponsor: Centre National de Formation et de Recherche en Sante Rurale

PhaseN/A
Planned participants2500
Who can joinAll sexes, 2 Months to no upper limit
Healthy volunteersNo

About this study

To date, the underlying causes of community-acquired fever, particularly non-malarial fever, are insufficiently documented in Guinea. Moreover, diagnostic capacity is limited, leading to inadequate prescription of antibiotics and antimalarials, as well as substantial delay in outbreak recognition. Thus, the investigators undertook a prospective observational multi-centric cohort study of febrile patients presenting at the emergency and outpatient department of selected health centers, districts and regional hospitals in four ecologically distinct sentinel health districts in Guinea.

This description comes directly from the study's public registry record.

Talk to the study team

Karifa Kourouma, MD, MSc  ·  +224-628-765-320  ·  KKourouma@maferinyah.org

Alexandre Delamou, MD, MPH, PhD  ·  +224-628-594-765  ·  adelamou@maferinyah.org

Always discuss trial participation with your own doctor first.

Locations (1)

Centre National de Formation et de Recherche en Santé RuraleMaférinya, Forécariah, GuineaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06122259